Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.4.8 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.617.1 (Kappa)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.4.3 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GS.7.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XWNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.1.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KG.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XDJNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HK.3.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GK.1.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.5.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.36.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.86.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LV.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HK.23NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GE.1.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.2.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JC.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KE.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FY.8.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.30NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.56NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JD.1.1.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LV.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.23EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GE.1.2.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
JN.2.2.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JC.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KE.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.8.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
C.30EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.56EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JD.1.1.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.64EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.8 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.7 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.41EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.90 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.23EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.30EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.1.1.12EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.87EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.33EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.46EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XDFEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.575.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.12EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GK.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.2.3.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-2902.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used